Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer

Hyunsoo Chung, Hanbyoul Cho, Candice Perry, Jaekyung Song, Kris Ylaya, Heejeong Lee, Jae Hoon Kim

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective: We investigated the clinical significance of ERp57 in the progression of cervical cancer. Methods: mRNA and protein expression of ERp57 in cervical neoplasias were examined. Results: ERp57 mRNA expression was significantly decreased in cervical cancers. Immunohistochemistry revealed that ERp57 expression in 123 cervical cancers was down-regulated compared to cervical intraepithelial neoplasias or normal tissues (p<0.001). Low ERp57 expression was significantly associated with worse overall survival (HR=12.19, p=0.018). Conclusions: Low ERp57 expression independently predicts a poor outcome for patients with cervical cancer, supporting the notion that ERp57 may be a promising novel cancer target.

Original languageEnglish
Pages (from-to)573-579
Number of pages7
JournalBiomarkers
Volume18
Issue number7
DOIs
Publication statusPublished - 2013 Nov

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Clinical Biochemistry
  • Health, Toxicology and Mutagenesis

Fingerprint Dive into the research topics of 'Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer'. Together they form a unique fingerprint.

  • Cite this